Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)

This study looks at two different ways to give cancer-fighting medications: through an IV drip or a quick under-the-skin injection. The goal is to see which method patients and doctors prefer for comfort and convenience.

You may be eligible if you have certain types of advanced cancer and are either starting treatment for the first time or are already receiving these specific immune-boosting drugs. You must be able to read and write in English to participate.

You will receive your medication either through an IV in your vein or an injection under the skin, depending on the study group. You will then share your thoughts and feelings about the process so researchers can understand your experience.

This study is currently recruiting volunteers and is taking place in Pittsburgh, Pennsylvania. You should talk to your doctor to see if this option is right for your specific health needs.